drugset / Trial / NCT05382494
Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children
Phase 4
Completed
130 enrolled
Murdoch Childrens Research Institute
Monash Health · collabRoyal Children's Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
MIST+ is studying a nasal spray to see if it will reduce the need for surgery for snoring. Children aged 3-12 are invited to take part. Snoring affects up to 10% of children and can cause sleeping problems and concentration or behavioural issues in the daytime. Currently the most common treatment for snoring is surgery to remove the tonsils and/or adenoids, however many children wait a long time to see a specialist. This research is trying to find if nasal sprays can help children with snoring, and whether this can reduce the need for surgery.
Timeline
- Start
- 2022-12-05
- Primary completion
- 2025-07-17
- Completion
- 2025-07-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mometasone furoate | Other / unclassified | 50 ug | Intranasal |